Lenz HJ - Search Results

1

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030).

Louie SG, Ely B, Lenz HJ, Albain KS, Gotay C, Coleman D, Raghavan D, Shields AF, Gold PJ, Blanke CD. Louie SG, et al. Among authors: lenz hj. Br J Cancer. 2013 Oct 1;109(7):1744-9. doi: 10.1038/bjc.2013.517. Epub 2013 Sep 10. Br J Cancer. 2013. PMID: 24022189 Free PMC article. Clinical Trial.

2

Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial.

Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Ortega A, et al. Leichman L, et al. Among authors: lenz hj. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1306-10. doi: 10.1016/0959-8049(95)00326-e. Eur J Cancer. 1995. PMID: 7577041 Clinical Trial.

3

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV. Metzger R, et al. Among authors: lenz hj. Clin Cancer Res. 1998 Oct;4(10):2371-6. Clin Cancer Res. 1998. PMID: 9796967

4

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Cancer Res. 2001 Dec 15;61(24):8654-8. Cancer Res. 2001. PMID: 11751380

5

Phase I study of bryostatin-1 in combination with cisplatin in treating patients with metastatic or unresectable solid tumors including non small-cell lung cancer.

Lenz HJ, Raghavan D, Doroshow J, Gandara DR. Lenz HJ, et al. Clin Lung Cancer. 1999 Nov;1(2):151-2. doi: 10.3816/clc.1999.n.013. Clin Lung Cancer. 1999. PMID: 14733667 No abstract available.

6

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

Iqbal S, Goldman B, Fenoglio-Preiser CM, Lenz HJ, Zhang W, Danenberg KD, Shibata SI, Blanke CD. Iqbal S, et al. Among authors: lenz hj. Ann Oncol. 2011 Dec;22(12):2610-2615. doi: 10.1093/annonc/mdr021. Epub 2011 Mar 17. Ann Oncol. 2011. PMID: 21415234 Free PMC article. Clinical Trial.

7

Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis.

Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V, Yang D, Chung HK, Choi D, LaBonte MJ, Ladner RD, Nagulapalli Venkata KC, Rosenberg DO, Petasis NA, Lenz HJ, Hong YK. Lee YS, et al. Among authors: lenz hj. Br J Cancer. 2012 May 22;106(11):1833-41. doi: 10.1038/bjc.2012.177. Br J Cancer. 2012. PMID: 22617157 Free PMC article.

8

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

Gordon MA, Gundacker HM, Benedetti J, Macdonald JS, Baranda JC, Levin WJ, Blanke CD, Elatre W, Weng P, Zhou JY, Lenz HJ, Press MF. Gordon MA, et al. Among authors: lenz hj. Ann Oncol. 2013 Jul;24(7):1754-1761. doi: 10.1093/annonc/mdt106. Epub 2013 Mar 22. Ann Oncol. 2013. PMID: 23524864 Free PMC article.

9

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.

El-Khoueiry AB, Rankin C, Siegel AB, Iqbal S, Gong IY, Micetich KC, Kayaleh OR, Lenz HJ, Blanke CD. El-Khoueiry AB, et al. Among authors: lenz hj. Br J Cancer. 2014 Feb 18;110(4):882-7. doi: 10.1038/bjc.2013.801. Epub 2014 Jan 14. Br J Cancer. 2014. PMID: 24423918 Free PMC article. Clinical Trial.

10

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.

Hochster HS, Uboha N, Messersmith W, Gold PJ, ONeil BH, Cohen D, Denlinger C, Cohen S, Leichman CG, Leichman L, Lenz HJ. Hochster HS, et al. Among authors: lenz hj. Cancer Chemother Pharmacol. 2015 Jan;75(1):17-23. doi: 10.1007/s00280-014-2609-3. Epub 2014 Oct 17. Cancer Chemother Pharmacol. 2015. PMID: 25322874 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

707 results

Search Page

Filters